|
|
|
|
|
|
|
M T W Th Fri |
|
25 September, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chris Klomp appears likely to be confirmed as deputy secretary of HHS by the full Senate after the finance committee advanced his nomination on Thursday. Sen. Sheldon Whitehouse (D-RI) joined Republicans backing Klomp in the 15-12 vote. |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
|
|
|
by Zachary Brennan
|
Pharmaceutical companies and industry groups are calling on the FDA to provide more details and examples about when sponsors can rely on one pivotal trial... | |
|
|
|
|
|
|
by Max Bayer
|
Nektar Therapeutics won $90 million in its lawsuit against Eli Lilly over a fractured licensing deal, a win for the biotech but a far smaller... | |
|
|
|
|
|
|
|
|
by Kyle LaHucik
|
A buzzy RNAi startup is going public in an upsized $446.3 million Nasdaq listing, adding to the biopharma industry's high IPO velocity. ADARx Pharmaceuticals, the... | |
|
|
|
|
|
|
by Ayisha Sharma
|
OXFORD, England — Making rare disease treatments economically attractive for drugmakers requires looking outside rare disease, according to experts interviewed by Endpoints News. The... | |
|
|
|
|
|
|
by Nicole DeFeudis
|
Merck’s Welireg won FDA approval on Friday for use in combination with Eisai’s Lenvima to treat certain kidney cancer patients. The combination will be... | |
|
|
|
|
|
